Testosterone inhibits the contractile responses to α1- adrenergic agonist, phenylephrine, associated with the release of intracellular calcium in rat aorta;La testosterona inhibe las respuestas contráctiles del agonista adrenérgico α1, fenilefrina, asociadas con la liberación de calcio intracelular en la aorta de rata

Gaceta Medica de Mexico

Volumn 142, Issue 1, 2006, Pages 1-8

  Castillo, Carlos ^a   Castillo, Enrique F ^a   López, Jorge ^a   López, Ruth M ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Adrenergic agonists; Intracellular Ca2+ release; Testosterone

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOGLUTETHIMIDE; CAFFEINE; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CYCLOHEXIMIDE; CYCLOPIAZONIC ACID; FLUTAMIDE; G PROTEIN COUPLED RECEPTOR; PHENYLEPHRINE; RYANODINE; SEROTONIN; TESTOSTERONE; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM; HEART CONTRACTION; HEART MUSCLE CONTRACTILITY; MUSCLE TONE; NONHUMAN; RAT; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; VASCULAR RING; ANIMAL; AORTA; CELL; DRUG EFFECT; IN VITRO STUDY; MALE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; VASODILATATION; WISTAR RAT;

ANIMALS; AORTA; CALCIUM; CELLS; MALE; MUSCLE CONTRACTION; PHENYLEPHRINE; RATS; RATS, WISTAR; TESTOSTERONE; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 33745027697     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Costarella CE, Stallone JN, Rutecki GW, Whittier FC. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther 1996;277:34-39.
2. Perusquía M, Hernández R, Morales MA, Campos MG, Villalon CM. Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta. Gen Pharmac 1996;27:181-185.
3. Honda H, Unemoto T, Kogo H. Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 1999;34:1232-1236.
4. + channel activation. J Appl Physiol 2001;91:2742-2750.
5. Yue PY, Chatterjee K, Beale C, Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995;91:1154-1160.
6. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 1996;94:2614-2619.
7. Tep-areenan P, Kendall DA, Randall MD. Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol 2002;135:735-40.
8. Tep-areenan P, Kendall DA, Randall MD. Mechanisms of vasorelaxation to testosterone in the rat aorta. Eur J Pharmacol 2003;465:125-132.
9. 1-adrenoceptor subtypes: functions and signaling. Can J Physiol Pharmacol 2000;78:267-292.
10. Putney JW. Capacitative calcium entry revisited. Cell Calcium 1990;11:611-634.
11. Noguera MA, D'Ocon MP. Evidence that depletion of internal calcium stores sensitive to noradrenaline elicits a contractile response dependent on extracellular calcium in rat aorta. Br J Pharmacol 1993;110:861-867.
12. 1-adrenoceptors in rat aorta. Naunyn-Schmiedeberg's Arch Pharmacol 1996;355:1-7.
13. 2+ pools in rat aorta. Naunyn-Schmiedeberg's Arch Pharmacol 1998;357:92-99.
14. Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 1997;59:365-393.
15. Falkenstein E, Tillmann H-C, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones - A focus on rapid, nongenomic effects. Pharmacol Rev 2000;52:513-555.
16. McLeod DG. Antiandrogenic drugs. Cancer 1993;71:1046-1049.
17. Perez N, Borja J. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer. J Int Med Res 1992;20:303-312.
18. Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 2001;281:H1720-H1727.
19. Wilson JD. Androgens. En: The Pharmacological Basis of Therapeutics. Hardman JD, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (Eds.). McGraw-Hill, 9a. Edición, New York, EUA, 1996, pp 1441-1457.
20. Webb C, McNeill J, Hayward C, Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 1999;100:1690-1696.
21. Giuseppe M, Rosano C, Leonardo F, Pagnotta P, Pelliccia F, Panina G, et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999;99:1666-1670.
22. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, et al. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997;49:157-230.
23. Felder CC, Singer-Lahat D, Mathes C. Voltage-independent calcium channels. Regulation by receptors and intracellular calcium stores. Biochem Pharmacol 1995;48:1997-2004.
24. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 1994;15:77-83.
25. 2 receptor antagonists in rat aorta. J Pharm Pharmacol 1999;51:953-957.
26. Willmer EN. Steroids and cell surfaces. Biol Rev 1961;36:368-398.
27. Clarke R, Van den Berg HW, Murphy RF. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17b-estradiol. J Natl Cancer Inst 1990;82:1702-1705.
28. Reddy AG, Shivaji S, Gupta PD. Effect of estradiol on the membrane fluidity of the rat vagina endothelial cells. J Steroid Biochem 1989;33:1229-1233.
29. Shivaji S, Jagannadham MV. Steroid-induced perturbation of membranes and its relevance to sperm acrosome reaction. Biochem Biophys Acta 1992;1108:99-109.
30. Falkenstein E, Norman AW, Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action (s). J Clin Endo Met 2000;85:2072-2075